A Pilot Study of the Immunologic Reconstitution in HIV-1 Infected Children Receiving Highly Active Antiretroviral Therapy With Combination Ritonavir, Nevirapine and Stavudine

NCT00001688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

DRUG: Ritonavir
DRUG: Nevirapine
DRUG: Stavudine

Sponsor

National Cancer Institute (NCI)